Clinical Trials Browser

Borderline Resectable Pancreatic Adenocarcinoma

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Stomach Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Pancreatic Neoplasms

Esophageal Neoplasms

Neoplasms, Stomach Neoplasms

Colorectal Neoplasms

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Gallbladder Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Locally Advanced Pancreatic Cancer

Appendiceal Neoplasms, Colorectal Neoplasms

Neoplasm Metastasis, Colorectal Neoplasms

Peritoneal Neoplasms, Stomach Neoplasms

Biliary Tract Neoplasms, Gastrointestinal Neoplasms

Pancreatic Neoplasms

Rectal Neoplasms, Colorectal Neoplasms

Pancreatic Adenocarcinoma

Adenocarcinoma, Mucinous, Carcinoma, Signet Ring Cell

Pancreatic Neoplasms

Colorectal Neoplasms

Clinical Stage I Gastric Cancer AJCC v8

Colorectal Neoplasms

Colorectal Neoplasms

Esophageal Neoplasms

Urachal cancer, Urinary Bladder Neoplasms, Urethral Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Stomach Neoplasms

Neoplasm Metastasis

Adenocarcinoma, Rectal Neoplasms

Locally Advanced Rectal Cancer

Bile Duct Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Disease Progression

Carcinoma, Hepatocellular, Cholangiocarcinoma

Colorectal Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Clinical Trials

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia

Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)

An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric Cancer

Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors

LyRICX

ILUSTRO

Toco-CoR

EDGE-Gastric

Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread

FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

TRIPP-FFX

ICARuS

BBOpCo

STOPGAP

NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer

A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer

Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer

METIMMOX-2

Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer

Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab

Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer

Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer

A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer

LIVERPEARL

A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia

Induction Chemotherapy for Locally Advanced Esophageal Cancer

Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant

JANUS

Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM

DANTE

TEDOPAM

NOAHS-ARC

ShorTrip

BOLSTER

mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma

PANIRINOX

NEO-IMPACT

Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic Cancer

Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer